InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Daniels Eric Joseph, Directeur du Développement. Director active across 1 company, notably Kiora Pharmaceuticals INC. Aggregated, 10 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €7k. History available since 21 October 2022. The latest transaction was disclosed on 1 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Daniels Eric Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
929 股@ US$1.9518.1% 占其流量Common StockSEC:0001372514-26-000032:0
6,533 股0Common StockSEC:0001372514-26-000014:0
238 股@ US$2.024.6% 占其流量Common StockSEC:0001372514-26-000007:0
7,772 股0Common StockSEC:0001372514-25-000035:0
7,355 股0Common StockSEC:0001372514-24-000094:0
1,431 股@ US$5.29100.0% 占其流量Common StockSEC:0001372514-24-000063:0
标准退出：2024年9月12日 (T+90)
62,500 股0Common StockSEC:0001372514-23-000149:0
15,600 股0Common StockSEC:0001372514-23-000034:0
10,000 股0Common StockSEC:0001104659-22-111246:0
9,520 股Common StockSEC:0001104659-21-142530:0
10 条申报中的 10 条
About Daniels Eric Joseph
Daniels Eric Joseph is Chief Development Officer. He has 10 filings in total, all associated with Kiora Pharmaceuticals INC, with buy transactions totaling EUR 7049 and no sell transactions in the sampled filings, over the period from 2021-11-22 to 2026-04-02. The modal transaction nature is Attribution.
